Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 06 04:00PM ET
1.44
Dollar change
-0.14
Percentage change
-8.86
%
Index- P/E- EPS (ttm)-0.21 Insider Own52.20% Shs Outstand12.85M Perf Week-2.70%
Market Cap18.50M Forward P/E- EPS next Y- Insider Trans0.10% Shs Float6.14M Perf Month-8.28%
Income-2.74M PEG- EPS next Q-0.06 Inst Own3.24% Short Float5.62% Perf Quarter6.67%
Sales0.00M P/S- EPS this Y- Inst Trans0.42% Short Ratio0.14 Perf Half Y-
Book/sh0.26 P/B5.55 EPS next Y- ROA-92.10% Short Interest0.34M Perf Year-
Cash/sh0.25 P/C5.75 EPS next 5Y- ROE-375.74% 52W Range0.85 - 4.00 Perf YTD-5.26%
Dividend Est.- P/FCF- EPS past 5Y- ROI-82.26% 52W High-64.00% Beta-
Dividend TTM- Quick Ratio2.84 Sales past 5Y0.00% Gross Margin- 52W Low69.21% ATR (14)0.27
Dividend Ex-Date- Current Ratio2.84 EPS Y/Y TTM-207.94% Oper. Margin- RSI (14)46.91 Volatility12.41% 27.56%
Employees3 Debt/Eq0.04 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price10.50
Option/ShortNo / No LT Debt/Eq0.00 EPS Q/Q-235.39% Payout- Rel Volume0.14 Prev Close1.58
Sales Surprise- EPS Surprise-150.00% Sales Q/Q- EarningsNov 27 Avg Volume2.55M Price1.44
SMA20-5.39% SMA50-8.26% SMA200-9.30% Trades Volume360,362 Change-8.86%
Feb-06-25 08:30AM
Jan-28-25 08:15AM
Jan-21-25 08:30AM
Jan-07-25 08:15AM
Dec-16-24 12:15PM
08:30AM Loading…
Dec-03-24 08:30AM
Nov-19-24 08:30AM
Oct-22-24 09:00AM
Oct-14-24 06:00AM
Oct-09-24 04:30PM
Sep-24-24 04:20PM
Sep-17-24 04:29PM
Sep-16-24 10:49AM
Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of novel and transformative drug therapies to treat cancer. It focuses on the research and development of immunotherapies for oncology. The company was founded by John S. Yu on June 17, 2013 and is headquartered in Los Angeles, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Murali RamachandranVP of Research and DevelopmentNov 25 '24Buy1.59200318133,057Nov 25 08:30 PM
Samuelson DougChief Financial OfficerNov 22 '24Buy1.502,5003,75060,796Nov 25 06:03 AM
Yu John SCEO and ChairmanNov 20 '24Buy1.444,0005,7605,341,837Nov 21 09:53 PM